Immature immune cells predict chances of survival following a heart attack

In the event of a severe heart attack, immature immune cells are released into the bloodstream from the bone marrow. A research team led by the University of Münster has demonstrated that the maturity level of neutrophils can be used to determine the short-term risk of death, and this can be assessed through a simple blood test. These findings have been published in the journal Nature Cardiovascular Research.

1 in 5 adults make health decisions based on what they see on social media despite widespread mistrust

Every few scrolls, another health expert appears on the screen. While some are genuinely qualified, others simply sound convincing enough to pass as one. With AI-generated content flooding feeds, avoiding such advice is becoming increasingly difficult. The way people access health advice has shifted, and for many, social media might be a primary source of information. We need to keep up with its impact because, unlike traditional health channels, these platforms often lack strong editorial checks, making it easier for misinformation to spread.

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a knowledge gap that has detrimental effects on patient prognosis, clinical trial recruitment and research that could lead to new therapies.

Are lung cancer tumors hijacking the nervous system?

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.

New tumor map identifies high-risk B-cell lymphoma standard therapy may miss

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particularly in high-risk patients for whom standard therapy offers little chance of cure. In the future, such patients could receive alternative, more effective therapies directly. In addition, experimental laboratory research provided initial clues to potential therapeutic targets. The study is published in Cancer Cell.